Annexin V-FITC Apoptosis Kit

Apoptosis assay cell type - HT-29

Experiment
Apoptosis assay cell type - HT-29
Product
Annexin V-FITC Apoptosis Kit from Biovision
Manufacturer
Biovision

Protocol tips

Upstream tips
- Cells were pretreated with CM and CF at concentrations required for 50% inhibition of growth
Protocol tips
- Always stain cells with Annexin before fixation (makes cell membrane leaky)

Publication protocol

To detect the apoptosis induction in HT-29 cells, for each assay, the cells were treated with CM and CF at concentrations required for 50% inhibition of growth of HT-29 cells (IC50) for 24 h (40 µg/mL). Untreated cells with 0.05% DMSO (v/v) vehicle served as negative control.

Full paper   Login or join for free to view the full paper.

Reviews

Annexin V-FITC Apoptosis Kit from Biovision has not yet been reviewed for this experiment

We'd love it if you would be the first to write a review!

Discussion

Start your discussion

Share your thoughts or question with experts in your field

Start a discussion

Papers

Check out relevant papers found by Labettor's AI that are relevant for performing Apoptosis assay cell type - HT-29 using Annexin V-FITC Apoptosis Kit from Biovision.

Paper title
Extracts Exert Cytotoxic and Apoptotic Effects against HT-29 Human Colon Adenocarcinoma Cells
Full paper
Login or join for free to view the full paper.

Manufacturer protocol

Download the product protocol from Biovision for Annexin V-FITC Apoptosis Kit below.

Download PDF Download manufacturer protocol

Videos

Check out videos that might be relevant for performing Apoptosis assay cell type - HT-29 using Annexin V-FITC Apoptosis Kit from Biovision. Please note that these videos are representative and steps or experiment specific processes must be kept in mind to expect desired results.

We haven't found any additional videos for this experiment / product combination yet.

Outsource your experiment

Fill out your contact details and receive price quotes in your Inbox

  Outsource experiment
Become shareholder Discussions About us Contact Privacy Terms